Mostrar el registro sencillo del ítem
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
dc.contributor.author | Camins A. | |
dc.contributor.author | Ettcheto M. | |
dc.contributor.author | Busquets O. | |
dc.contributor.author | Manzine P.R. | |
dc.contributor.author | Castro-Torres R.D. | |
dc.contributor.author | Beas-Zarate C. | |
dc.contributor.author | Verdaguer E. | |
dc.contributor.author | Sureda F.X. | |
dc.contributor.author | Bulló M. | |
dc.contributor.author | Olloquequi J. | |
dc.contributor.author | Auladell C. | |
dc.contributor.author | Folch J. | |
dc.date.accessioned | 2020-09-02T22:14:07Z | |
dc.date.available | 2020-09-02T22:14:07Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1080/13543784.2019.1552677 | |
dc.identifier.citation | 28, 1, 93-97 | |
dc.identifier.issn | 13543784 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/3876 | |
dc.description | [No abstract available] | |
dc.language.iso | en | |
dc.publisher | Taylor and Francis Ltd | |
dc.subject | Alzheimer’s disease | |
dc.subject | glucagon | |
dc.subject | glucagon-like peptide | |
dc.subject | glucose-dependent insulinotropic peptide | |
dc.subject | type 2 diabetes | |
dc.subject | gastric inhibitory polypeptide | |
dc.subject | glucagon like peptide | |
dc.subject | glucagon receptor agonist | |
dc.subject | gastric inhibitory polypeptide receptor | |
dc.subject | glucagon like peptide 1 | |
dc.subject | glucagon receptor | |
dc.subject | hormone receptor | |
dc.subject | Alzheimer disease | |
dc.subject | Article | |
dc.subject | human | |
dc.subject | late onset disorder | |
dc.subject | nonhuman | |
dc.subject | Alzheimer disease | |
dc.subject | animal | |
dc.subject | drug development | |
dc.subject | molecularly targeted therapy | |
dc.subject | pathophysiology | |
dc.subject | procedures | |
dc.subject | Alzheimer Disease | |
dc.subject | Animals | |
dc.subject | Drug Development | |
dc.subject | Glucagon-Like Peptide 1 | |
dc.subject | Humans | |
dc.subject | Molecular Targeted Therapy | |
dc.subject | Receptors, Gastrointestinal Hormone | |
dc.subject | Receptors, Glucagon | |
dc.title | Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease | |
dc.type | Article |